Deal Snapshot
Q-STATE BIOSCIENCES COMBINES WITH PAIRNOMIX TO FORM CNS PRECISION MEDICINE COMPANY
Wednesday 05 December 2018

US-based genomic services company Q-State Biosciences, Inc. has closed its series A financing and has joined with Minneapolis-based Pairnomix, LLC to create a precision medicine company focused on rare and devastating central nervous system diseases, the company said.
Q-State said it is the only company now offering comprehensive genomic services ranging from genetic sequencing to mutation modelling and screening to targeted antisense oligonucleotide design, with application to individuals as well as populations.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 05/12/2018
Target: Pairnomix, LLC,  
Country: USA
Sector: Biotechnology
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Q-State Biosciences
Comment:
Terms of the deal were not disclosed

Options